Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Completes EraGen Purchase for $34M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that it has completed its $34 million all-cash purchase of EraGen Biosciences.

Luminex said the acquisition of the Madison, Wis.-based molecular diagnostics firm would add between $5 million and $7 million in revenues to Luminex in 2011. The deal is expected to be dilutive to 2011 earnings and accretive to 2012 earnings on a GAAP basis.

Luminex said last week when the deal was announced that EraGen is expected to remain headquartered in Madison.

EraGen develops molecular diagnostic technologies for infectious disease and genetic applications. Its products include its FDA-cleared MultiCode-RTx Herpes Simplex Virus 1&2 kit for detecting and typing HSV-1 or HSV-2 from vaginal lesion swab specimens.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.